6 research outputs found
ΠΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ°-2b ΠΏΡΠΈ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠ΅ Ρ Π΄Π΅ΡΠ΅ΠΉ
A prospective cohort study was conducted to assess the effect of a recombinant interferon alpha-2b prophylactic course on cyto-immunological parameters of induced sputum in children with mild asthma, the main trigger of exacerbation of which was respiratory viral infections.We examined 40 children aged 1 to 7 years with (mean age β 4.8 Β± 0.2 years), half of whom received a course of recombinant interferon alpha-2b. The authors detected respiratory viruses in scrapings from throat and nose (PCR method) and evaluated the different cell counts, also the levels of interleukin-10, tumor necrosis factor alpha, interferon alpha and immunoglobulin E on the 1st and 30th day of the study (ELISA method) were determined in sputum.The number of asthma exacerbations, triggered by respiratory viral infection, decreased in 4.5 times against. In children who received recombinant interferon alpha-2b the count of sputum eosinophils and the number of children with sputum eosinophilia (β₯3 %) reduced. After two months the level of nasal eosinophils was 30% lower than the start level. The level of IgE in induced sputum decreased by 35%, but the level of IL-10 was increased by 1.5 times. 75% of parents whose children received recombinant interferon alpha-2b, note positive effect of this drug.There were no adverse events to receive the drug in any case. Thus, the use of recombinant interferon alpha-2b in children with virus-induced asthma to reduce episodes of exacerbations associated with acute respiratory diseases can be recommended.ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΠΊΠΎΠ³ΠΎΡΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Ρ ΡΠ΅Π»ΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ Π²Π»ΠΈΡΠ½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΡΡΡΠ° ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ°-2b (ΡΡΠΏΠΏΠΎΠ·ΠΈΡΠΎΡΠΈΠΈ ΠΈ Π³Π΅Π»Ρ) Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΈ ΡΠΈΡΠΎΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΌΠΎΠΊΡΠΎΡΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Π»Π΅Π³ΠΊΠΎΠΉ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ, ΠΎΡΠ½ΠΎΠ²Π½ΡΠΌ ΡΡΠΈΠ³Π³Π΅ΡΠΎΠΌ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΡ ΠΊΠΎΡΠΎΡΠΎΠΉ ΡΠ²Π»ΡΠ»ΠΈΡΡ ΠΎΡΡΡΡΠ΅ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠ΅ Π²ΠΈΡΡΡΠ½ΡΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ.Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΎ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΎ 40 Π΄Π΅ΡΠ΅ΠΉ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 1 Π΄ΠΎ 7 Π»Π΅Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ β 4,8 Β± 0,2 Π»Π΅Ρ), ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Π° ΠΈΠ· ΠΊΠΎΡΠΎΡΡΡ
ΠΏΠΎΠ»ΡΡΠ°Π»ΠΈ ΠΊΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ°-2b ΠΏΠΎ ΡΡ
Π΅ΠΌΠ΅ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 29 Π΄Π½Π΅ΠΉ. ΠΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΡΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π½Π°Π·Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΊΡΠ΅ΡΠ° ΠΈ ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΌΠΎΠΊΡΠΎΡΡ, ΠΌΠ°Π·ΠΊΠΎΠ² ΠΈΠ· Π·Π΅Π²Π° ΠΈ Π½ΠΎΡΠ° Π½Π° ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠ΅ Π²ΠΈΡΡΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ¦Π , ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ€Π Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΡΡΠΎΠ²Π½ΠΈ ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π°-10, ΡΠ°ΠΊΡΠΎΡΠ° Π½Π΅ΠΊΡΠΎΠ·Π° ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π°Π»ΡΡΠ°, ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ° ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° Π, Π½Π° 1-ΠΉ ΠΈ 30-ΠΉ Π΄Π΅Π½Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΠΉ Π°ΡΡΠΌΡ Π½Π° ΡΠΎΠ½Π΅ ΠΎΡΡΡΡΡ
ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ Π² 4,5 ΡΠ°Π·Π°. Π£ Π΄Π΅ΡΠ΅ΠΉ, ΠΏΠΎΠ»ΡΡΠΈΠ²ΡΠΈΡ
ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ Π°Π»ΡΡΠ°-2b, ΠΎΡΠΌΠ΅ΡΠ΅Π½ΠΎ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Π½Π° ΡΡΠΎΠ²Π½Π΅ ΡΠ»ΠΈΠ·ΠΈΡΡΡΡ
ΠΎΠ±ΠΎΠ»ΠΎΡΠ΅ΠΊ Π½ΠΎΡΠ° ΠΈ Π±ΡΠΎΠ½Ρ
ΠΎΠ². ΠΠ½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ½ΠΈΠ·ΠΈΠ»ΠΎΡΡ ΠΊΠ°ΠΊ ΡΡΠ΅Π΄Π½Π΅Π΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΡΠΎΠ·ΠΈΠ½ΠΎΡΠΈΠ»ΠΎΠ² Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ β Π² 7,6 ΡΠ°Π·, ΡΠ°ΠΊ ΠΈ ΡΠΈΡΠ»ΠΎ Π΄Π΅ΡΠ΅ΠΉ Ρ ΡΠΎΠ·ΠΈΠ½ΠΎΡΠΈΠ»ΠΈΠ΅ΠΉ ΠΌΠΎΠΊΡΠΎΡΡ (β₯ 3%). Π£ΡΠΎΠ²Π΅Π½Ρ ΡΠΎΠ·ΠΈΠ½ΠΎΡΠΈΠ»ΠΎΠ² Π½Π°Π·Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΊΡΠ΅ΡΠ° ΡΠ΅ΡΠ΅Π· 2 ΠΌΠ΅ΡΡΡΠ° ΠΎΡ Π½Π°ΡΠ°Π»Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠ» Π½ΠΈΠΆΠ΅ ΠΏΠ΅ΡΠ²ΠΎΠ½Π°ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π½Π° 30%. ΠΠ°ΡΠ°Π»Π»Π΅Π»ΡΠ½ΠΎ ΠΏΡΠΎΠΈΠ·ΠΎΡΠ»ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ IgE Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ Π½Π° 35% ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ IL-10 Π² 1,5 ΡΠ°Π·Π°. Π Π³ΡΡΠΏΠΏΠ΅ Π΄Π΅ΡΠ΅ΠΉ, ΠΏΠΎΠ»ΡΡΠ°Π²ΡΠΈΡ
ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ Π°Π»ΡΡΠ°-2b, 75% ΡΠΎΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎ Π²ΡΡΠΊΠ°Π·Π°Π»ΠΈΡΡ ΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΠΎΠΌ ΠΊΡΡΡΠ΅. ΠΠ΅ Π±ΡΠ»ΠΎ ΠΎΡΠΌΠ΅ΡΠ΅Π½ΠΎ Π½Π΅ΠΆΠ΅Π»Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ²Π»Π΅Π½ΠΈΠΉ Π½Π° ΠΏΡΠΈΠ΅ΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Π½ΠΈ Π² ΠΎΠ΄Π½ΠΎΠΌ ΡΠ»ΡΡΠ°Π΅. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°ΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΊΡΡΡΠ° ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ°-2b Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Π²ΠΈΡΡΡ-ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ Π΄Π»Ρ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΡ ΡΠΏΠΈΠ·ΠΎΠ΄ΠΎΠ² ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΠΉ, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
Ρ ΠΎΡΡΡΡΠΌΠΈ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ
Π’he prophylactic efficacy of a recombinant interferon alfa-2b drug in children with bronchial asthma
A prospective cohort study was conducted to assess the effect of a recombinant interferon alpha-2b prophylactic course on cyto-immunological parameters of induced sputum in children with mild asthma, the main trigger of exacerbation of which was respiratory viral infections.We examined 40 children aged 1 to 7 years with (mean age β 4.8 Β± 0.2 years), half of whom received a course of recombinant interferon alpha-2b. The authors detected respiratory viruses in scrapings from throat and nose (PCR method) and evaluated the different cell counts, also the levels of interleukin-10, tumor necrosis factor alpha, interferon alpha and immunoglobulin E on the 1st and 30th day of the study (ELISA method) were determined in sputum.The number of asthma exacerbations, triggered by respiratory viral infection, decreased in 4.5 times against. In children who received recombinant interferon alpha-2b the count of sputum eosinophils and the number of children with sputum eosinophilia (β₯3 %) reduced. After two months the level of nasal eosinophils was 30% lower than the start level. The level of IgE in induced sputum decreased by 35%, but the level of IL-10 was increased by 1.5 times. 75% of parents whose children received recombinant interferon alpha-2b, note positive effect of this drug.There were no adverse events to receive the drug in any case. Thus, the use of recombinant interferon alpha-2b in children with virus-induced asthma to reduce episodes of exacerbations associated with acute respiratory diseases can be recommended
ΠΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ°-2b ΠΏΡΠΈ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠ΅ Ρ Π΄Π΅ΡΠ΅ΠΉ
A prospective cohort study was conducted to assess the effect of a recombinant interferon alpha-2b prophylactic course on cyto-immunological parameters of induced sputum in children with mild asthma, the main trigger of exacerbation of which was respiratory viral infections.We examined 40 children aged 1 to 7 years with (mean age β 4.8 Β± 0.2 years), half of whom received a course of recombinant interferon alpha-2b. The authors detected respiratory viruses in scrapings from throat and nose (PCR method) and evaluated the different cell counts, also the levels of interleukin-10, tumor necrosis factor alpha, interferon alpha and immunoglobulin E on the 1st and 30th day of the study (ELISA method) were determined in sputum.The number of asthma exacerbations, triggered by respiratory viral infection, decreased in 4.5 times against. In children who received recombinant interferon alpha-2b the count of sputum eosinophils and the number of children with sputum eosinophilia (β₯3 %) reduced. After two months the level of nasal eosinophils was 30% lower than the start level. The level of IgE in induced sputum decreased by 35%, but the level of IL-10 was increased by 1.5 times. 75% of parents whose children received recombinant interferon alpha-2b, note positive effect of this drug.There were no adverse events to receive the drug in any case. Thus, the use of recombinant interferon alpha-2b in children with virus-induced asthma to reduce episodes of exacerbations associated with acute respiratory diseases can be recommended.ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΠΊΠΎΠ³ΠΎΡΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Ρ ΡΠ΅Π»ΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ Π²Π»ΠΈΡΠ½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΡΡΡΠ° ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ°-2b (ΡΡΠΏΠΏΠΎΠ·ΠΈΡΠΎΡΠΈΠΈ ΠΈ Π³Π΅Π»Ρ) Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΈ ΡΠΈΡΠΎΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΌΠΎΠΊΡΠΎΡΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Π»Π΅Π³ΠΊΠΎΠΉ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ, ΠΎΡΠ½ΠΎΠ²Π½ΡΠΌ ΡΡΠΈΠ³Π³Π΅ΡΠΎΠΌ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΡ ΠΊΠΎΡΠΎΡΠΎΠΉ ΡΠ²Π»ΡΠ»ΠΈΡΡ ΠΎΡΡΡΡΠ΅ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠ΅ Π²ΠΈΡΡΡΠ½ΡΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ.Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΎ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΎ 40 Π΄Π΅ΡΠ΅ΠΉ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 1 Π΄ΠΎ 7 Π»Π΅Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ β 4,8 Β± 0,2 Π»Π΅Ρ), ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Π° ΠΈΠ· ΠΊΠΎΡΠΎΡΡΡ
ΠΏΠΎΠ»ΡΡΠ°Π»ΠΈ ΠΊΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ°-2b ΠΏΠΎ ΡΡ
Π΅ΠΌΠ΅ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 29 Π΄Π½Π΅ΠΉ. ΠΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΡΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π½Π°Π·Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΊΡΠ΅ΡΠ° ΠΈ ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΌΠΎΠΊΡΠΎΡΡ, ΠΌΠ°Π·ΠΊΠΎΠ² ΠΈΠ· Π·Π΅Π²Π° ΠΈ Π½ΠΎΡΠ° Π½Π° ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠ΅ Π²ΠΈΡΡΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ¦Π , ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ€Π Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΡΡΠΎΠ²Π½ΠΈ ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π°-10, ΡΠ°ΠΊΡΠΎΡΠ° Π½Π΅ΠΊΡΠΎΠ·Π° ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π°Π»ΡΡΠ°, ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ° ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° Π, Π½Π° 1-ΠΉ ΠΈ 30-ΠΉ Π΄Π΅Π½Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΠΉ Π°ΡΡΠΌΡ Π½Π° ΡΠΎΠ½Π΅ ΠΎΡΡΡΡΡ
ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ Π² 4,5 ΡΠ°Π·Π°. Π£ Π΄Π΅ΡΠ΅ΠΉ, ΠΏΠΎΠ»ΡΡΠΈΠ²ΡΠΈΡ
ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ Π°Π»ΡΡΠ°-2b, ΠΎΡΠΌΠ΅ΡΠ΅Π½ΠΎ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Π½Π° ΡΡΠΎΠ²Π½Π΅ ΡΠ»ΠΈΠ·ΠΈΡΡΡΡ
ΠΎΠ±ΠΎΠ»ΠΎΡΠ΅ΠΊ Π½ΠΎΡΠ° ΠΈ Π±ΡΠΎΠ½Ρ
ΠΎΠ². ΠΠ½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ½ΠΈΠ·ΠΈΠ»ΠΎΡΡ ΠΊΠ°ΠΊ ΡΡΠ΅Π΄Π½Π΅Π΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΡΠΎΠ·ΠΈΠ½ΠΎΡΠΈΠ»ΠΎΠ² Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ β Π² 7,6 ΡΠ°Π·, ΡΠ°ΠΊ ΠΈ ΡΠΈΡΠ»ΠΎ Π΄Π΅ΡΠ΅ΠΉ Ρ ΡΠΎΠ·ΠΈΠ½ΠΎΡΠΈΠ»ΠΈΠ΅ΠΉ ΠΌΠΎΠΊΡΠΎΡΡ (β₯ 3%). Π£ΡΠΎΠ²Π΅Π½Ρ ΡΠΎΠ·ΠΈΠ½ΠΎΡΠΈΠ»ΠΎΠ² Π½Π°Π·Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΊΡΠ΅ΡΠ° ΡΠ΅ΡΠ΅Π· 2 ΠΌΠ΅ΡΡΡΠ° ΠΎΡ Π½Π°ΡΠ°Π»Π° ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠ» Π½ΠΈΠΆΠ΅ ΠΏΠ΅ΡΠ²ΠΎΠ½Π°ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π½Π° 30%. ΠΠ°ΡΠ°Π»Π»Π΅Π»ΡΠ½ΠΎ ΠΏΡΠΎΠΈΠ·ΠΎΡΠ»ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ IgE Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ Π½Π° 35% ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ IL-10 Π² 1,5 ΡΠ°Π·Π°. Π Π³ΡΡΠΏΠΏΠ΅ Π΄Π΅ΡΠ΅ΠΉ, ΠΏΠΎΠ»ΡΡΠ°Π²ΡΠΈΡ
ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ Π°Π»ΡΡΠ°-2b, 75% ΡΠΎΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎ Π²ΡΡΠΊΠ°Π·Π°Π»ΠΈΡΡ ΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΠΎΠΌ ΠΊΡΡΡΠ΅. ΠΠ΅ Π±ΡΠ»ΠΎ ΠΎΡΠΌΠ΅ΡΠ΅Π½ΠΎ Π½Π΅ΠΆΠ΅Π»Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΡΠ²Π»Π΅Π½ΠΈΠΉ Π½Π° ΠΏΡΠΈΠ΅ΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Π½ΠΈ Π² ΠΎΠ΄Π½ΠΎΠΌ ΡΠ»ΡΡΠ°Π΅. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°ΡΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΊΡΡΡΠ° ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½Π° Π°Π»ΡΡΠ°-2b Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Π²ΠΈΡΡΡ-ΠΈΠ½Π΄ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ Π΄Π»Ρ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΡ ΡΠΏΠΈΠ·ΠΎΠ΄ΠΎΠ² ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΠΉ, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
Ρ ΠΎΡΡΡΡΠΌΠΈ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ
Recommended from our members
Environmental Changes of the Aral Sea (Central Asia) in the Holocene: Major Trends
From the 20th International Radiocarbon Conference held in Kona, Hawaii, USA, May 31-June 3, 2009.Changes of the Aral Sea level have been observed in 3 sediment boreholes, 2 outcrops, and associated archaeological sites. The obtained results are supported by 25 radiocarbon dates. Major trends of lake-level changes have been reconstructed in some detail for the last 2000 yr, and additional data provide an outline of fluctuations throughout the Holocene. Several distinct changes are shown to precede the modern, human-induced regression of the Aral Sea. These include: 1) the latest maximum in the 16th-20th centuries AD (53 m asl); 2) a Medieval "Kerderi" minimum of the 12th-15th centuries AD (29 m asl); 3) the early Medieval maximum of the 4th-11th centuries AD (52 m asl); and 4) a near BC/AD lowstand, whose level is not well established. Since then, events are only inferred from sparse data. The studied cores contain several sandy layers representing the lowering of the lake level within the Holocene, including the buried shore-bar of ~4500 cal BP (38 m asl), and shallow-water sediments of ~5600 cal BP (44 m asl), 7200 cal BP (28 m asl), and 8000 cal BP (26.5 m asl).The Radiocarbon archives are made available by Radiocarbon and the University of Arizona Libraries. Contact [email protected] for further information.Migrated from OJS platform February 202